CARLSBAD, Calif.--(BUSINESS WIRE)--Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced that it has signed an exclusive license agreement for ErrASE, a commercially available DNA error-correction kit developed by Novici Biotech LLC to increase accuracy and accelerate the pace of research in the field of synthetic biology.
